Otonomy, Inc.
OTICDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001493566
Otonomy, Inc. was delisted in 2023; its insiders filed their last Form 4 on Dec 30, 2022; 40 institutions reported holding it in 13F filings for Q3 2022, worth $8.42M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Otonomy, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Otonomy, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Weber David Allen | Director | 285,863 | Dec 30, 2022 | 0 |
| Cayer Paul E | President and CFBO | 183,733 | Dec 30, 2022 | 0 |
| Capps Vickie L | Director | 3,400 | Nov 29, 2022 | 0 |
| Breitmeyer James B | Director | – | Jun 23, 2022 | 0 |
| Broadfoot Jill Marie | Director | – | Jun 23, 2022 | 0 |
| Lichter Jay | Director | – | Jun 23, 2022 | 0 |
| Schroeder Theodore R | Director | – | Jun 23, 2022 | 0 |
| Kennedy Ciara | Director | – | Jun 23, 2022 | 0 |
| McGill Iain | Director | – | Jun 23, 2022 | 0 |
| Savel Robert Michael II | Chief Technical Officer | 145,735 | Mar 29, 2022 | 0 |
| Foster Alan Charles | Chief Scientific Officer | 177,017 | Mar 29, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2022 (view filing)4:18 PM ET | Nov 28 | 1 day | Capps Vickie LDirector | SSale | −42.2K | $0.1028 | −$4.34K | −92.6%3.40K after | |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Weber David AllenPresident & CEO | SSale | −19.3K | $2.40 | −$46.3K | −4.9%377.5K after | 2 lots |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Savel Robert Michael IIChief Technical Officer | SSale | −5.70K | $2.40 | −$13.7K | −3.8%145.7K after | 2 lots |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Foster Alan CharlesChief Scientific Officer | SSale | −4.39K | $2.40 | −$10.5K | −2.4%177.0K after | 2 lots |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Cayer Paul ECh. Financial & Business Offcr | SSale | −9.64K | $2.40 | −$23.1K | −4.1%223.8K after | 2 lots |